The Visa board of directors has asked shareholders to oppose a policy advocating the company address an apparent lack of health insurance coverage for detransitioners harmed by sex change interventions, such as hormone therapy and surgeries.
The National Legal and Policy Center (NLPC) is bringing forward a proposal titled “Gender-Based Compensation Gaps and Associated Risks,” referred to as Proposal 4, at Visa’s annual shareholder meeting on Tuesday. The proposal suggests Visa may be at risk of litigation if it fails to provide insurance coverage for those seeking to pause or reverse the impact of cosmetic medical procedures aimed at changing their bodies to look like the opposite sex.
The proposal notes that while Visa offers insurance plans that explicitly pay for the “medical, chemical, and/or surgical treatments to aid their ‘transition’ to their non-biological…
